Back to Authors

Rubin, DT

A5104235718 | I40347166

Mayo Clinic

University of Chicago

Citations 4

Long-term use of ozanimod in patients with moderately to severely active ulcerative colitis

Zeitschrift für Gastroenterologie | November 25, 2025 | Volume: 60 | Issue: 08 | Pages: e428-e428

10.1055/s-0042-1754606

ASSOCIATION BETWEEN HISTOLOGICAL INDICES AND ULCERATIVE COLITIS ACTIVITY MEASURES AMONG PATIENTS IN THE HICKORY (ETROLIZUMAB) OPEN-LABEL INDUCTION (OLI) COHORT

Zeitschrift für Gastroenterologie | January 29, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0040-1712255

Etrolizumab induction therapy improves patient-reported outcomes, endoscopic activity and histologic severity in patients with moderate-severe Ulcerative colitis after failure of anti-TNF therapy: results from the HICKORY open label induction trial

Zeitschrift für Gastroenterologie | September 22, 2020 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0040-1716048

CAPSULE RETENTION IN CROHN DISEASE: A META-ANALYSIS

Endoscopy | May 13, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0039-1681198